| Absorption | 
      | Blood-Brain Barrier | BBB- | 0.9961 | 
      | Human Intestinal Absorption | HIA- | 0.9270 | 
      | Caco-2 Permeability | Caco2- | 0.8956 | 
      | P-glycoprotein Substrate | Substrate | 0.5603 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.9626 | 
                                                     | Non-inhibitor | 0.9971 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9689 | 
        
            | Distribution | 
        
      | Subcellular localization | Lysosome | 0.5707 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8297 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8447 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.5825 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.9253 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9402 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9401 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9399 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.8309 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9884 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9998 | 
                                                                    | Non-inhibitor | 0.9031 | 
      | AMES Toxicity | Non AMES toxic | 0.9132 | 
      | Carcinogens | Non-carcinogens | 0.5363 | 
      | Fish Toxicity | High FHMT | 0.9722 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.7152 | 
      | Honey Bee Toxicity | Low HBT | 0.7369 | 
      | Biodegradation | Not ready biodegradable | 0.9844 | 
      | Acute Oral Toxicity | IV | 0.6698 | 
      | Carcinogenicity (Three-class) | Non-required | 0.6941 |